ClinicalTrials.Veeva

Menu

Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD (VR-TMS)

Yale University logo

Yale University

Status

Not yet enrolling

Conditions

Obsessive-Compulsive Disorder

Treatments

Device: Virtual Reality

Study type

Interventional

Funder types

Other

Identifiers

NCT06442527
2000037937

Details and patient eligibility

About

This study will focus on the use of Virtual Reality (VR) technology in patients receiving treatment using Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)

Enrollment

5 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants must be at least 18 years old
  • Patients must have been clinically evaluated by a Yale Interventional Psychiatry Service physician who has deemed them appropriate to receive TMS for the treatment of OCD
  • Ability and willingness, in the investigator's judgement, to comply with the study procedure and study requirements.

Exclusion criteria

  • Hearing or visual impairment to the degree that would interfere with ability to see or hear VR content.
  • Difficulty in understanding spoken or written English
  • Pregnancy
  • History of seizure disorder
  • Unable to provide informed consent
  • Dementia or other cognitive disorder or intellectual disability that would impair the subject's ability to understand the study procedure (per investigator judgment)
  • Any implanted medical device, risk of interference with which by the VR device in the investigator's judgment can put patient at additional undue risk.
  • Any other medical or psychiatric comorbidity that the investigator judges would put the participant at additional undue risk due to study participation or would impair subject's ability to participate in the study.
  • Was previously enrolled/randomized into the study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

5 participants in 1 patient group

Treatment Group
Experimental group
Description:
This single arm will include all participants of the study, who will all receive the intervention
Treatment:
Device: Virtual Reality

Trial contacts and locations

1

Loading...

Central trial contact

Mina Ansari

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems